Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.33 |
| ▸ | AR | P10275 | 3/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.31 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL27085270 | 0.79 | L3MBTL1 (0.35) | — | |
| SCHEMBL19812737 | 0.73 | KDM4E (0.50) | — | |
| SCHEMBL29817937 | 0.69 | ALDH1A1 (0.55) | FFAR4 | |
| SCHEMBL2520368 | 0.68 | MAPT (0.41) | — | |
| SCHEMBL2528786 | 0.67 | GABRA1 (0.42) | FFAR4CYP11B2ARGABRA1GABRG2 | |
| SCHEMBL57346 | 0.66 | TRPV4 (0.61) | TRPV4CYP11B1CYP11B2ARMAOA | |
| SCHEMBL30919072 | 0.66 | TRPV4 (0.61) | TRPV4CYP11B1CYP11B2ARMAOA | |
| SCHEMBL2526428 | 0.66 | CDK4 (0.38) | FFAR4ARPGR | |
| SCHEMBL2523972 | 0.66 | HCRTR2 (0.39) | TRPV4FFAR4CYP11B1CYP11B2MAOA | |
| SCHEMBL17871934 | 0.66 | AR (0.51) | FFAR4CYP11B1CYP11B2AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1749011-A1 | BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2007-02-07 | — | — | EP | disclosed |
| WO-2005118593-A1 | BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-12-15 | — | — | WO | disclosed |